COVID-19 Rapid Test Kits Market

COVID-19 rapid test kits are a type of diagnostic test that can detect the presence of the SARS-CoV-2 virus in a person's body, which causes COVID-19. These tests typically yield results within a few minutes to an hour and can be performed at the point of care, such as a doctor's office, clinic, or testing facility. COVID-19 rapid test kit manufacturers, distributors, and suppliers, as well as healthcare organisations and government agencies that purchase and use them, make up the market for these tests.

The Global COVID-19 Rapid Test Kits Market is projected to grow from $ *Billion in 2018 to $ *Billion by 2031, at a CAGR of **% during the forecast period.

Antigen tests, also known as rapid diagnostic tests, can produce results in minutes and are less expensive than PCR tests, making them popular for screening large groups of people quickly. Companies are working on at-home testing kits based on self-collected nasal swab samples. This allows people to put their skills to the test in the privacy of their own homes. Some rapid test kits are now being developed that can detect multiple pathogens in a single test, such as COVID-19 and influenza. 

Some of the Major key Players are Abbott Laboratories; F. Hoffmann-La Roche AG; Quidel Corporation; Thermo Fisher Scientific Inc.; Becton, Dickinson and Company.